PARP Inhibitors in Ovarian Cancer: A Trailblazing and Transformative Journey

Panagiotis A Konstantinopoulos1, Ursula A Matulonis2

  • 1Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston Massachusetts.

Insights

Poly (ADP-ribose) polymerase (PARP) inhibitors are revolutionizing ovarian cancer treatment, particularly for BRCA-mutated cancers. These drugs are now approved for maintenance therapy after chemotherapy in recurrent ovarian cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian cancer, especially the high-grade serous subtype, is characterized by homologous recombination (HR) deficiencies.
  • Aberrant DNA repair pathways are a hallmark of these tumors, creating therapeutic vulnerabilities.

Purpose of the Study:

  • To review the clinical impact and therapeutic potential of PARP inhibitors in ovarian cancer.
  • To highlight the role of HR deficiency and BRCA mutations in treatment response.

Main Methods:

  • Review of clinical trial data and preclinical research on PARP inhibitors.
  • Analysis of mechanisms of action, including synthetic lethality in BRCA-mutated cells.

Main Results:

  • PARP inhibitors have demonstrated significant efficacy in treating ovarian cancer.
  • These agents are approved for maintenance therapy in recurrent ovarian cancer following platinum chemotherapy response.
  • Treatment is particularly effective in patients with BRCA-mutated (BRCAm) ovarian cancer.

Conclusions:

  • PARP inhibitors represent a major advancement in ovarian cancer therapy.
  • Targeting DNA repair deficiencies, especially in BRCAm tumors, is a key strategy.
  • Further research is ongoing to expand the utility of PARP inhibitors.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
60.1K
Transformers01:26

Transformers

A device that transforms voltages from one value to another using induction is called a transformer. A transformer consists of two separate coils, or windings, wrapped around the same soft iron core. However, they are electrically insulated from each other.
The iron core has a substantial relative permeability. Therefore, the magnetic field lines generated due to the current in one winding are almost entirely confined within the core, such that the same magnetic flux permeates each turn of both...
1.9K
Transformation01:26

Transformation

Microbial communities are dynamic environments where cell lysis releases free DNA into the surroundings. Other cells can take up this extracellular DNA through a process known as transformation.When a cell incorporates this foreign DNA into its genome, resulting in genetic modification, the process is known as transformation. Cells capable of this process are termed competent. Competence can be natural, as observed in certain bacteria and archaea, or artificially induced in the...
1.1K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
4.1K
Transformations of Functions I01:29

Transformations of Functions I

A function's graph can be modified by changing its position or size without altering its overall shape. These transformations allow the graph to be moved across the coordinate plane while preserving its pattern and structure. One of the most common transformations is shifting, which repositions the graph without distorting it.When the output of a function is adjusted by adding or subtracting a constant, the graph shifts vertically. A positive value moves the graph upward, while a negative value...
201